LINX® is a quarter-sized beaded titanium device that is inserted during a minimally-invasive laparoscopic surgery. It stops stomach acid from entering the esophagus from the moment it is implanted. Unlike other procedures to treat reflux, LINX® is implanted around the outside of the Lower Esophageal Sphincter (LES) and does not alter the anatomy of the stomach. The procedure preserves normal physiological function, allowing food to pass through.

Dr. Carlos Anciano, assistant professor of thoracic and foregut surgery and director of minimally invasive thoracic surgery at East Carolina University, and Dr. James Speicher, assistant professor of thoracic surgery, are the only physicians in Vidant Health’s 29-county service area who perform the surgery. 

Many commercial health insurance companies are covering the cost of the procedure.

Prior to the availability of this device, the treatment for patients diagnosed with Gastroesophageal Reflux Disease (GERD) was frequently a lifetime prescription of anti-reflux medication to reduce the acidity level in the stomach.

español »